(Q48245049)

9 February 2018

title

Alzheimer's beta-amyloid peptides can activate the early components of complement classical pathway in a C1q-independent manner (English)

1 reference

9 February 2018

0 references

4

1 reference

9 February 2018

author name string

L Bergamaschini

1

1 reference

9 February 2018

S Canziani

2

1 reference

9 February 2018

B Bottasso

3

1 reference

9 February 2018

P Braidotti

5

1 reference

9 February 2018

A Agostoni

6

1 reference

9 February 2018

publication date

1 March 1999

1 reference

9 February 2018

Clinical and Experimental Immunology

published in

1 reference

9 February 2018

volume

115

1 reference

9 February 2018

issue

3

1 reference

9 February 2018

page(s)

526-533

1 reference

9 February 2018

Complement C1-inhibitor expression in Alzheimer's disease

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1905247

Activation of the contact system in cerebrospinal fluid of patients with Alzheimer disease

26 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1905247

The intrinsic coagulation/kinin-forming cascade: assembly in plasma and cell surfaces in inflammation

26 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1905247

Aggregation state-dependent activation of the classical complement pathway by the amyloid beta peptide.

26 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1905247

Aspartate residue 7 in amyloid beta-protein is critical for classical complement pathway activation: implications for Alzheimer's disease pathogenesis

26 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1905247

beta-Amyloid converts an acute phase injury response to chronic injury responses

26 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1905247

Inflammatory mechanisms in neurodegeneration and Alzheimer's disease: the role of the complement system

26 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1905247

Early complement components in Alzheimer's disease brains.

26 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1905247

Morphology and toxicity of Abeta-(1-42) dimer derived from neuritic and vascular amyloid deposits of Alzheimer's disease

26 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1905247

Water-soluble Abeta (N-40, N-42) oligomers in normal and Alzheimer disease brains

26 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1905247

beta-Amyloid-mediated vasoactivity and vascular endothelial damage.

26 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1905247

beta-Amyloid activates complement by binding to a specific region of the collagen-like domain of the C1q A chain.

26 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1905247

Alzheimer's disease: a central role for amyloid

26 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1905247

Ultrastructural localization of complement membrane attack complex (MAC)-like immunoreactivity in brains of patients with Alzheimer's disease

26 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1905247

Expression and cellular localization of messenger RNA for plasminogen activator inhibitor type 1 in human astrocytomas in vivo

26 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1905247

Hageman factor and its binding sites are present in senile plaques of Alzheimer's disease

26 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1905247

Enhanced aggregation and beta structure of amyloid beta peptide after coincubation with C1q.

26 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1905247

Decreased levels of C1q in cerebrospinal fluid of living Alzheimer patients correlate with disease state

26 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1905247

Amyloid-beta aggregation: selective inhibition of aggregation in mixtures of amyloid with different chain lengths

26 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1905247

Complement C1 inhibitor is produced by brain tissue and is cleaved in Alzheimer disease

26 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1905247

In vitro stimulation of tissue-type plasminogen activator by Alzheimer amyloid β-peptide analogues

26 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1905247

Activation of the classical pathway of complement by Hageman factor fragment

26 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1905247

Kinetics of the activation of plasminogen by human tissue plasminogen activator. Role of fibrin

26 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1905247

Inactivation of factor XII active fragment in normal plasma. Predominant role of C-1-inhibitor

26 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1905247

Mechanisms of activation of the classical pathway of complement by Hageman factor fragment

26 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1905247

The conversion of C'IS to C'1 esterase by plasmin and trypsin

26 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1905247

The inhibition of plasmin, plasma kallikrein, plasma permeability factor, and the C'1r subcomponent of the first component of complement by serum C'1 esterase inhibitor

26 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1905247

Detection of in vitro and in vivo cleavage of high molecular weight kininogen in human plasma by immunoblotting with monoclonal antibodies

26 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1905247

Immunoblotting studies of coagulation factor XII, plasma prekallikrein, and high molecular weight kininogen

26 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1905247

Kinetics of interaction of C1 inhibitor with complement C1s.

26 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1905247

Assembly and aggregation properties of synthetic Alzheimer's A4/beta amyloid peptide analogs

26 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1905247

Production and secretion of plasminogen in cultured rat brain microglia

26 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1905247

Complement activation by beta-amyloid in Alzheimer disease

26 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1905247

Microglia isolated from rat brain secrete a urokinase-type plasminogen activator

26 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1905247

Complement C1q does not bind monomeric beta-amyloid

26 August 2018

1 reference

12 December 2020

Modulation of the antigenicity of C1r and C1s by C1 inactivator

1 reference

12 December 2020

A newly described control mechanism of complement activation in patients with mixed cryoglobulinemia (cryoglobulins and complement)

1 reference

12 December 2020

63 Inactivation of trypsin-like enzymes with peptides of arginine chloromethyl ketone

1 reference

12 December 2020

Activation of complement and kinin systems after thrombolytic therapy in patients with acute myocardial infarction. A comparison between streptokinase and recombinant tissue-type plasminogen activator

1 reference

12 December 2020

Neuroglial-mediated immunoinflammatory responses in Alzheimer's disease: complement activation and therapeutic approaches

1 reference

12 December 2020

10.1046/J.1365-2249.1999.00835.X

Identifiers

DOI

1 reference

9 February 2018

PMC publication ID

1905247

0 references

1 reference

9 February 2018